Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Quinazolinone derivatives as PARP inhibitors

Quinazolinone derivatives as PARP inhibitors

US Patent 10150757 · Granted Dec 11, 2018

Estimated economic value: $104,760,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibacterial compounds2024
Heteroaromatic compounds having activity against RSV2023
2,4-diaminoquinazoline derivatives and medical uses thereof2023
Cycloalkyl substituted pyrazolopyrimidines having activity against RSV2022
Pyrazolopyrimidines having activity against the respiratory syncytial virus (RSV2022
Heterocyclic compounds as antibacterials2021
Antibacterial compounds2021
Aryl substituted pyrimidines for use in influenza virus infection2021
RSV antiviral pyrazolo- and triazolo-pyrimidine compounds2021
Dihydropyranopyrimidines for the treatment of viral infections2021
Antibacterial compounds and uses thereof2021
Pyrimidine prodrugs for the treatment of viral infections and further diseases2021